Breast cancer experts Kevin Kalinsky, MD, and Komoal Jhaveri, MD, focus on decoding breast cancer biomarkers through TAILORx, RxPONDER and other landmark trials
February 2, 2023
OncLive
This article is best read on the publisher's website. Click the button below to read it in full.
